This site uses cookies to improve your experience and to provide services and advertising. By continuing to browse, you agree to the use of cookies described in our Cookies Policy. You may change your settings at any time but this may impact on the functionality of the site. To learn more see our Cookies Policy.
#Open journalism No news is bad news

Your contributions will help us continue to deliver the stories that are important to you

Support The Journal
Dublin: 20 °C Wednesday 5 August, 2020

New national cancer drug fund in pipeline

However, finding the finance for that fund won’t be easy, the NCCP’s director warns.

Image: via Creative Commons

A NEW NATIONAL budget for cancer drugs will be set up before the end of this year, according to a report in the Irish Medical News today.

The new fund has identified 11 drugs – which make up around 80 per cent of current expenditure on oncology medication – which will be funded through the demand-led scheme.

The move will see control for expensive adjuvant cancer therapies removed  from hospitals.

National Cancer Control Programme (NCCP) director Dr Susan O’Reilly said that negotiations on how the fund will operate are still going on between the NCCP, the HSE and the Primary Care Reimbursement Service. She also said that financing the drugs scheme would prove difficult “because there is no new money”.

Read more about the planned fund in Paul Mulholland’s report in the Irish Medical News >

  • Share on Facebook
  • Email this article

Read next: